mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.002 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.003 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.003 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |